Opportunity

Federal Register #OP-1883

Federal Reserve service-fee updates and CDC request for West Nile vaccine profile input

Buyer

Federal Reserve System

Posted

November 16, 2026

Identifier

OP-1883

This notice covers Federal Reserve service-fee schedules and a separate CDC request for input on a West Nile virus vaccine profile. - Government entities: Board of Governors of the Federal Reserve System; Centers for Disease Control and Prevention (CDC), within the Department of Health and Human Services. - Federal Reserve announcement: The 2027 private-sector adjustment factor (PSAF) is $35.3 million. Updated prices cover Check Services, FedACH Services, Fedwire Funds Service, National Settlement Service, Fedwire Securities Service, FedNow Service, and FedLine Solutions. - Changes include a new FRFS Access Fee, revised FedLine charges, increases to selected Check and Fedwire Funds fees, and decreases to Fedwire Securities fees. - Most mature priced services are projected to recover their costs; Check Services is projected to under-recover. - Separate CDC item: CDC seeks public input on a proposed target product profile for a human West Nile virus vaccine. This is a request for comments, not a vaccine purchase. - Procurement status: No products, quantities, OEMs, or prospective vendors are identified. The $35.3 million PSAF is not a contract value.

Description

The Board of Governors of the Federal Reserve System approved the 2027 private-sector adjustment factor (PSAF) of $35.3 million and the 2027 fee schedules for Federal Reserve priced services and electronic access. The fees are established under the Monetary Control Act of 1980, which requires priced-service fees to be based on direct and indirect costs, including the PSAF. The new fee schedules become effective January 1, 2027. Copies of the schedules are available from Federal Reserve Financial Services.

View original listing